Evoke Pharma (EVOK) Tops Q4 EPS by 7c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.12), $0.07 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance